Karvy Therapeutics Pvt Ltd, a active private limited company, was established on 24 February 1989 in Haripar Pal, Gujarat, India. Engaging in specialty chemicals within the manufacturing sector, it holds CIN: U24231GJ1989PTC011930. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹1.50 Cr and a paid-up capital of ₹1.50 Cr.
Formerly known as Charmy Therapeutic And Chemicals Private Limited, Charmy Therapeutics And Chemicals Private Limited. It upholds a compliant status. Employing 11 professional, Its leadership includes Parag Jagdish Kothari (Director), Hem Parag Kothari (Director), Jagdish Raichand Kothari (Director). Past directors included Parag Jagdish Kothari, Jagdish Raichand Kothari, Shilpa Parag Kothari. It holds ₹21.87 Cr open charges and ₹23.35 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Survey No. 29, Kalawad Road, Tal. Lodhika, Dist. Rajkot, Haripar Pal, Gujarat, 360005.
U24231GJ1989PTC011930
011930
24 February 1989
₹1.50 Cr
₹1.50 Cr
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Karvy Therapeutics Pvt Ltd — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Parag Jagdish Kothari | Director | 24 Feb 1989 | Current |
| Hem Parag Kothari | Director | 01 Apr 2025 | Current |
| Jagdish Raichand Kothari | Director | 10 Oct 2002 | Current |
| Shilpa Parag Kothari | Director | 30 Mar 2007 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 28 Apr 2017 | Past |
| Pramod Abcsdd | Director | 28 Apr 2017 | Past |
| Pramod Abcsdd | Director | 28 Apr 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Karvy Therapeutics Pvt Ltd, for the financial year ended 2023, experienced significant reduction in revenue, with a 19.31% decrease. The company also saw a substantial fall in profitability, with a 72.79% decrease in profit. The company's net worth moved up by a moderate rise of 7.94%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Karvy Therapeutics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹218,719,998.00
₹233,537,024.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 02 Jun 2025 | Hdfc Bank Limited | ₹1.77 M | Open |
| 10 Oct 2022 | Hdfc Bank Limited | ₹1.03 M | Open |
| 25 Nov 2021 | Hdfc Bank Limited | ₹2.16 M | Open |
| 14 Jun 2017 | Others | ₹21.38 Cr | Open |
| 15 Nov 2021 | Hdfc Bank Limited | ₹1.86 M | Satisfied |
Explore comprehensive loan charge details -
Karvy Therapeutics has a workforce of 11 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Karvy Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Karvy Therapeutics's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge with Others of Rs. 21.38 Cr registered on 14 Jun 2017 with Charge ID 100105080 was modified on 19 Jul 2025. was completed.
Progress on A charge with Hdfc Bank Limited amounted to Rs. 0.18 Cr with Charge ID 101103537 was registered on 02 Jun 2025. was documented.
The activity Hem Parag Kothari was appointed as a Director was appointed as a Director on 01 Apr 2025 & has been associated with this company since 8 months 26 days . was completed.
Progress on A charge registered on 15 Nov 2021 via Charge ID 100510229 with Hdfc Bank Limited was fully satisfied on 07 Nov 2024. was documented.
The activity Karvy Therapeutics Pvt Ltd last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Karvy Therapeutics Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad. was recorded as a recent event.
The CIN of Karvy Therapeutics Pvt Ltd is U24231GJ1989PTC011930.
Karvy Therapeutics Pvt Ltd is headquartered at Survey No. 29, Kalawad Road, Tal. Lodhika, Dist. Rajkot, Haripar Pal, Gujarat, 360005.
Karvy Therapeutics Pvt Ltd was incorporated on 24 February 1989.
The current directors of Karvy Therapeutics Pvt Ltd are
The primary industry of Karvy Therapeutics Pvt Ltd is Manufacturing.
Karvy Therapeutics Pvt Ltd is unlisted.
The authorized capital of Karvy Therapeutics Pvt Ltd is ₹1.50 Cr, and the paid-up capital is ₹1.50 Cr.
The compliance status of Karvy Therapeutics Pvt Ltd is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX